Kasparian Nadine A, McLoone Jordana K, Butow Phyllis N
School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Kensington, New South Wales, Australia.
Arch Dermatol. 2009 Dec;145(12):1415-27. doi: 10.1001/archdermatol.2009.308.
To conduct a systematic review of the literature to identify the prevalence of, and demonstrated risk factors for, psychological distress among individuals affected by, or at high risk of developing, melanoma. For a substantial subset of patients, the diagnosis and/or treatment of cutaneous malignant melanoma may cause significant psychological distress.
Using the MEDLINE, PsycINFO, and CINAHL databases, published studies (1988 to March 2008) of individuals affected by melanoma were included if they examined the demographic, clinical, psychological, and/or social correlates of emotional distress.
Searches were restricted to publications in English and were supplemented by citation lists in retrieved articles and contact with researchers.
A total of 356 articles were critically appraised by 2 reviewers to assess eligibility and clinical evidence level. A total of 44 studies met the inclusion criteria.
Approximately 30% of patients with melanoma reported clinically relevant levels of psychological distress, as measured by a range of validated scales, with symptoms of anxiety more prevalent than depression. A number of empirically demonstrated risk factors for distress were identified, including female sex, younger age, lower education, visibility of affected body site, lack of social support, and negative appraisal of melanoma.
Routine psychological screening of patients with melanoma is widely recommended as standard practice; however, standard screening measures may have limited sensitivity and specificity as demonstrated by the wide range of results reported in this review. Development of a brief screening tool that incorporates empirically supported risk factors is recommended to improve the timely identification and support of those patients most susceptible to adverse psychological outcomes.
对文献进行系统综述,以确定黑色素瘤患者或黑色素瘤高危人群中心理困扰的患病率及已证实的风险因素。对于相当一部分患者而言,皮肤恶性黑色素瘤的诊断和/或治疗可能会导致严重的心理困扰。
使用MEDLINE、PsycINFO和CINAHL数据库,纳入1988年至2008年3月发表的有关黑色素瘤患者的研究,这些研究需考察了情绪困扰的人口统计学、临床、心理和/或社会相关因素。
检索限于英文出版物,并通过检索文章中的参考文献列表以及与研究人员联系进行补充。
两名评审员对总共356篇文章进行了严格评估,以评估其合格性和临床证据水平。共有44项研究符合纳入标准。
通过一系列经过验证的量表测量,约30%的黑色素瘤患者报告有临床相关程度的心理困扰,焦虑症状比抑郁症状更为普遍。确定了一些经实证证明的困扰风险因素,包括女性、年龄较小、教育程度较低、患部可见、缺乏社会支持以及对黑色素瘤的负面评价。
广泛推荐对黑色素瘤患者进行常规心理筛查作为标准做法;然而,正如本综述所报告的广泛结果所示,标准筛查措施的敏感性和特异性可能有限。建议开发一种纳入经实证支持的风险因素的简短筛查工具,以改善对那些最易出现不良心理结果的患者的及时识别和支持。